{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:50:37Z","timestamp":1793508637330,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.drudis.2024.103888","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T02:39:57Z","timestamp":1705804797000},"page":"103888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Revolutionizing viral disease treatment: Phase separation and lysosome\/exosome targeting as new areas and new paradigms for antiviral drug research"],"prefix":"10.1016","volume":"29","author":[{"given":"Shaoqing","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1156-1036","authenticated-orcid":false,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.103888_b0005","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cell.2021.02.013","article-title":"Antivirals with common targets against highly pathogenic viruses","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2024.103888_b0010","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/molecules27030850","article-title":"Newly emerging strategies in antiviral drug discovery: dedicated to Prof. Dr. Erik De Clercq on occasion of his 80th anniversary","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2024.103888_b0015","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1039\/D0CS01084G","article-title":"Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses","volume":"50","author":"Ma","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.drudis.2024.103888_b0020","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","article-title":"Phenotypic drug discovery: recent successes, lessons learned and new directions","volume":"21","author":"Vincent","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2024.103888_b0025","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2174\/0929867322666150209151209","article-title":"Target based drug design \u2014 a reality in virtual sphere","volume":"22","author":"Verma","year":"2015","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.drudis.2024.103888_b0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/pathogens12020243","article-title":"Phase separation: the robust modulator of innate antiviral signaling and SARS-CoV-2 infection","volume":"12","author":"Zheng","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.drudis.2024.103888_b0035","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1021\/acs.jmedchem.0c01689","article-title":"Targeting lysosomal degradation pathways: new strategies and techniques for drug discovery","volume":"64","author":"Pei","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2024.103888_b0040","doi-asserted-by":"crossref","first-page":"3356467","DOI":"10.1155\/2022\/3356467","article-title":"Harnessing the therapeutic potential of exosomes: a novel strategy for anticancer and antiviral therapy","volume":"2022","author":"Clinton","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.drudis.2024.103888_b0045","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.tim.2022.06.005","article-title":"Phase separation in viral infections","volume":"30","author":"Li","year":"2022","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.drudis.2024.103888_b0050","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1074\/jbc.TM118.001192","article-title":"The molecular language of membraneless organelles","volume":"294","author":"Gomes","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.103888_b0055","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41467-021-22297-8","article-title":"GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.103888_b0060","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41467-022-29266-9","article-title":"PCBP2 maintains antiviral signaling homeostasis by regulating cGAS enzymatic activity via antagonizing its condensation","volume":"13","author":"Gu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.103888_b0065","doi-asserted-by":"crossref","first-page":"D460","DOI":"10.1093\/nar\/gkac783","article-title":"PhaSepDB in 2022: annotating phase separation-related proteins with droplet states, co-phase separation partners and other experimental information","volume":"51","author":"Hou","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.103888_b0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.sbi.2017.12.007","article-title":"IDPs in macromolecular complexes: the roles of multivalent interactions in diverse assemblies","volume":"49","author":"Fung","year":"2018","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2018.12.035","article-title":"Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates","volume":"176","author":"Alberti","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2024.103888_b0080","article-title":"Negri bodies and other virus membrane-less replication compartments","volume":"1867","author":"Nevers","year":"2020","journal-title":"BBA-MOL Cell Res"},{"key":"10.1016\/j.drudis.2024.103888_b0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41580-020-00303-z","article-title":"A framework for understanding the functions of biomolecular condensates across scales","volume":"22","author":"Lyon","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0090","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1038\/s41467-023-41018-x","article-title":"Visualizing single-molecule conformational transition and binding dynamics of intrinsically disordered proteins","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.103888_b0095","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41586-023-06329-5","article-title":"Extreme dynamics in a biomolecular condensate","volume":"619","author":"Galvanetto","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.103888_b0100","doi-asserted-by":"crossref","first-page":"W329","DOI":"10.1093\/nar\/gky384","article-title":"IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding","volume":"46","author":"M\u00e9sz\u00e1ros","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2024.103888_b0105","doi-asserted-by":"crossref","first-page":"e1000376","DOI":"10.1371\/journal.pcbi.1000376","article-title":"Prediction of protein binding regions in disordered proteins","volume":"5","author":"M\u00e9sz\u00e1ros","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12859-022-04599-w","article-title":"Prediction of liquid\u2013liquid phase separating proteins using machine learning","volume":"23","author":"Chu","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.drudis.2024.103888_b0115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31486","article-title":"Pi-Pi contacts are an overlooked protein feature relevant to phase separation","volume":"7","author":"Vernon","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.drudis.2024.103888_b0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.celrep.2016.05.076","article-title":"A concentration-dependent liquid phase separation can cause toxicity upon increased protein expression","volume":"16","author":"Bolognesi","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2024.103888_b0125","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/bioinformatics\/btu310","article-title":"PLAAC: a web and command-line application to identify proteins with prion-like amino acid composition","volume":"30","author":"Lancaster","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2024.103888_b0130","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/bioinformatics\/btm325","article-title":"Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential","volume":"23","author":"Zhang","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2024.103888_b0135","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3390\/molecules23081958","article-title":"Next-generation drugs and probes for chromatin biology: from targeted protein degradation to phase separation","volume":"23","author":"Cermakova","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2024.103888_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100260","article-title":"1,6-Hexanediol, commonly used to dissolve liquid\u2013liquid phase separated condensates, directly impairs kinase and phosphatase activities","volume":"296","author":"D\u00fcster","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.103888_b0145","doi-asserted-by":"crossref","first-page":"e107711","DOI":"10.15252\/embj.2021107711","article-title":"Liquid\u2013liquid phase separation underpins the formation of replication factories in rotaviruses","volume":"40","author":"Geiger","year":"2021","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2024.103888_b0150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41586-021-03703-z","article-title":"A condensate-hardening drug blocks RSV replication in vivo","volume":"595","author":"Risso-Ballester","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.103888_b0155","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s13238-021-00832-z","article-title":"Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2","volume":"12","author":"Zhao","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.drudis.2024.103888_b0160","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acschembio.2c00908","article-title":"Screen for modulation of nucleocapsid protein condensation identifies small molecules with anti-coronavirus activity","volume":"18","author":"Quek","year":"2023","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0165","doi-asserted-by":"crossref","first-page":"e3001425","DOI":"10.1371\/journal.pbio.3001425","article-title":"SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA","volume":"19","author":"Jack","year":"2021","journal-title":"PLoS Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111251","article-title":"Scaffolding viral protein NC nucleates phase separation of the HIV-1 biomolecular condensate","volume":"40","author":"Monette","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2024.103888_b0175","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1111\/j.1742-4658.2008.06564.x","volume":"275","author":"Peng","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.drudis.2024.103888_b0180","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.molcel.2020.11.041","article-title":"Genomic RNA elements drive phase separation of the SARS-CoV-2 nucleocapsid","volume":"80","author":"Iserman","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2024.103888_b0185","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1021\/ja050918w","article-title":"Conformational constraint as a means for understanding RNA-aminoglycoside specificity","volume":"127","author":"Blount","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2024.103888_b0190","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1073\/pnas.91.21.9765","article-title":"Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics","volume":"91","author":"Guichard","year":"1994","journal-title":"Proc Nati Acad Sci U S A"},{"key":"10.1016\/j.drudis.2024.103888_b0195","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.molcel.2019.11.003","article-title":"Targeting UBE4A revives viperin protein in epithelium to enhance host antiviral defense","volume":"77","author":"Yuan","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2024.103888_b0200","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41556-021-00710-0","article-title":"Targeting liquid\u2013liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity","volume":"23","author":"Wang","year":"2021","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0205","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing targeted protein degradation for cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2024.103888_b0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10879","article-title":"Phase transitions in the assembly of multivalent signalling proteins","volume":"483","author":"Li","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.103888_b0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41421-023-00544-0","article-title":"BRD4-targeting PROTAC as a unique tool to study biomolecular condensates","volume":"9","author":"Shi","year":"2023","journal-title":"Cell Discov"},{"key":"10.1016\/j.drudis.2024.103888_b0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0225","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1096\/fj.15-271148","article-title":"Role of LIMP-2 in the intracellular trafficking of \u03b2-glucosidase in different human cellular models","volume":"29","author":"Malini","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2024.103888_b0230","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.apsb.2019.10.003","article-title":"Targeting autophagy-related protein kinases for potential therapeutic purpose","volume":"10","author":"Xiang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.drudis.2024.103888_b0235","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.drudis.2024.103888_b0240","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ncb0910-814","article-title":"Eaten alive: a history of macroautophagy","volume":"12","author":"Yang","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0245","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/cells8080849","article-title":"HSPA8\/HSC70 in immune disorders: a molecular rheostat that adjusts chaperone-mediated autophagy substrates","volume":"8","author":"Bonam","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2024.103888_b0250","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.cell.2020.10.039","article-title":"\u03b2-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway","volume":"183","author":"Ghosh","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2024.103888_b0255","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fmicb.2020.00733","article-title":"Herpes simplex virus: the hostile guest that takes over your home","volume":"11","author":"Banerjee","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2024.103888_b0260","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1038\/s41467-019-13659-4","article-title":"SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection","volume":"10","author":"Gassen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.103888_b0265","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/s41598-018-19421-y","article-title":"Metabolomics profiling reveals differential adaptation of major energy metabolism pathways associated with autophagy upon oxygen and glucose reduction","volume":"8","author":"Weckmann","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.103888_b0270","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1038\/s41467-021-24007-w","article-title":"SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals","volume":"12","author":"Gassen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.103888_b0275","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.drudis.2024.103888_b0280","doi-asserted-by":"crossref","first-page":"e1009706","DOI":"10.1371\/journal.ppat.1009706","article-title":"Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors","volume":"17","author":"Prabhakara","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.drudis.2024.103888_b0285","doi-asserted-by":"crossref","first-page":"17279","DOI":"10.18632\/oncotarget.13973","article-title":"Tumour-derived exosomes as a signature of pancreatic cancer \u2014 liquid biopsies as indicators of tumour progression","volume":"8","author":"Nuzhat","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2024.103888_b0290","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/vaccines7030102","article-title":"The role of extracellular vesicles in viral infection and transmission","volume":"7","author":"Urbanelli","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.drudis.2024.103888_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102664","article-title":"New insight into the role of exosomes in vitiligo","volume":"19","author":"Wong","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.drudis.2024.103888_b0300","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4049\/jimmunol.1500891","article-title":"Cutting edge: regulation of exosome secretion by the integral MAL protein in T cells","volume":"195","author":"Ventimiglia","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.drudis.2024.103888_b0305","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7150\/thno.21945","article-title":"Exosome theranostics: biology and translational medicine","volume":"8","author":"He","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2024.103888_b0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.drudis.2024.103888_b0315","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","article-title":"Exosomes \u2014 vesicular carriers for intercellular communication","volume":"21","author":"Simons","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.drudis.2024.103888_b0320","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: the virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2024.103888_b0325","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2024.103888_b0330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcmgh.2022.09.012","article-title":"Presence of intact hepatitis B virions in exosomes","volume":"15","author":"Wu","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.drudis.2024.103888_b0335","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ni.2647","article-title":"Exosomes mediate the cell-to-cell transmission of IFN-\u03b1-induced antiviral activity","volume":"14","author":"Li","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.drudis.2024.103888_b0340","doi-asserted-by":"crossref","first-page":"293","DOI":"10.31083\/j.fbl2710293","article-title":"Exosomes as anticancer drug delivery vehicles: prospects and challenges","volume":"27","author":"Zhang","year":"2022","journal-title":"Front Biosci"},{"key":"10.1016\/j.drudis.2024.103888_b0345","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ymthe.2018.02.016","article-title":"miRNAs targeting ICP4 and delivered to susceptible cells in exosomes block HSV-1 replication in a dose-dependent manner","volume":"26","author":"Wang","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.drudis.2024.103888_b0350","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.7150\/thno.33925","article-title":"Extracellular vesicles expressing a single-chain variable fragment of an HIV-1 specific antibody selectively target Env+ tissues","volume":"9","author":"Zou","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2024.103888_b0355","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ymthe.2020.09.026","article-title":"EVs containing host restriction factor IFITM3 inhibited ZIKV infection of fetuses in pregnant mice through trans-placenta delivery","volume":"29","author":"Zou","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.drudis.2024.103888_b0360","doi-asserted-by":"crossref","first-page":"20200186","DOI":"10.1002\/VIW.20200186","article-title":"Exosome therapeutics for COVID-19 and respiratory viruses","volume":"2","author":"Popowski","year":"2021","journal-title":"VIEW"},{"key":"10.1016\/j.drudis.2024.103888_b0365","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fmicb.2016.01765","article-title":"Ebola VP40 in exosomes can cause immune cell dysfunction","volume":"7","author":"Pleet","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2024.103888_b0370","doi-asserted-by":"crossref","first-page":"e01022","DOI":"10.1128\/JVI.01022-18","article-title":"Epstein-Barr virus microRNA miR-BART5-3p inhibits p53 expression","volume":"92","author":"Zheng","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2024.103888_b0375","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/JVI.05901-11","article-title":"Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells","volume":"86","author":"Yu","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2024.103888_b0380","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.omtn.2019.05.023","article-title":"Targeting exosomal EBV-LMP1 transfer and miR-203 expression via the NF-\u03baB pathway: the therapeutic role of aspirin in NPC","volume":"17","author":"Zuo","year":"2019","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624000138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624000138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:11:34Z","timestamp":1761225094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624000138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1359644624000138"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.103888","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revolutionizing viral disease treatment: Phase separation and lysosome\/exosome targeting as new areas and new paradigms for antiviral drug research","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.103888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103888"}}